跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VAXNEUVANCE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VAXNEUVANCE
Authorized
STANDARD
VAXNEUVANCE
Merck Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4451ba35ef96b788
Company
Merck Canada Inc
Type
Standard
Approval Details
Approval Id
4451ba35ef96b788
Drug Approval Canada Name
VAXNEUVANCE
Product Name
VAXNEUVANCE
Status
Marketed
Status Date
2022-09-02
Original Market Date
2022-09-02
Din
02522403
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intramuscular
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07AL02 PNEUMOCOCCUS, PURIFIED POLYSACC.ANTIGEN CONJUGATED
Atc Name
j 07 al 02
Aig Number
1663275001
Company Name
Merck Canada Inc
Company Address
16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7
Active Ingredients
CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN
30 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B
4 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5
2 MCG / 0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F
2 MCG / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4451ba35ef96b788
Type
Standard
Back to Health Canada Approvals